Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Adult-onset Latent Autoimmune Diabetes
Clinical trial NCT02407899 · COMPLETED
Trial details
- NCT number
- NCT02407899
- Sponsor
- Second Xiangya Hospital of Central South University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2020-12-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.